Hi Ruby,
I share your positive outlook for the company and Dr G.
The HKSE listing is forecast in Jan-Mar 19, from the ASX ANN on 8 Aug.
The NASDAQ listing is forecast in Jan-Feb 19, from the ASX ANN on 2 Oct.
So it’s not clear to me which will be first.
Irrespective, there will need to be some ‘big ticket items’ in the upcoming announcements to prime potential new investors, including CFDA for Prizma, contracts (not just MOUs) for distribution of Prizma and Patch, revenue from IDTFs, etc.
It’s helpful to remember that Dr G will need to get the revenue ramping up quickly to $30M by 8 May 19 to get his substantial performance shares.
My guess is that he’ll do everything possible to keep his holding above 50%, so with the NASDAQ listing he’ll need these performance shares to do this. In the meantime, if the company needs more cash, he’ll just increase his loan.
- Forums
- ASX - By Stock
- GMV
- Ann: Acquisition of Telerhythmics LLC
Ann: Acquisition of Telerhythmics LLC, page-359
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online